I think these ASX blue chips shares are primed for a major rebound in 2026

2025 was not kind to these shares. Here's why things could be better next year.

Key points
  • CSL Ltd is well-positioned for a rebound due to its robust presence in global healthcare and ongoing investments, despite recent market anxieties and temporary operational challenges.
  • WiseTech Global's CargoWise platform retains strong growth potential amid recent setbacks; with a recovery in sentiment and successful business adjustments, it could experience a significant upswing.
  • The article highlights opportunities arising from market impatience, encouraging a long-term perspective to capitalise on undervalued high-quality stocks.

Every market cycle produces its winners and losers. And sometimes, the losers aren't poor-quality companies at all, they are simply dealing with temporary headwinds.

That's what makes times like these so interesting. Several high-quality ASX blue chips have been marked down over the past year, not because their businesses are broken, but because the market has lost patience.

For investors who are willing to look beyond the next quarter, that disconnect can create attractive entry points.

Here are two ASX blue chip shares I believe are primed for a major rebound in 2026.

Two men laughing while bouncing on bouncy balls.

Image source: Getty Images

CSL Ltd (ASX: CSL)

CSL has spent decades earning its reputation as one of the highest-quality companies on the ASX. Its plasma therapies, vaccines, and specialty medicines give it a deeply entrenched position in global healthcare, which is a sector where scale, expertise, and regulatory trust matter enormously.

Yet despite this, CSL shares have been hit hard in 2025. Concerns over a margin recovery at CSL Behring, uncertainty surrounding the Seqirus demerger, weak influenza vaccine rates in the United States, and noise around US tariff policy have clouded what remains a fundamentally strong long-term outlook.

Strip out the market anxiety, and the underlying story hasn't changed for this biotech. Plasma collections continue to rise, new therapies are advancing through its R&D pipeline, and CSL is investing heavily in North American manufacturing to support future growth. The company's earnings power and competitive moat remain intact.

It is rare to see CSL trading at such a meaningful discount to its long-term averages. If sentiment improves in 2026, this blue chip ASX share could be one of the ASX's rebound stories.

Wisetech Global Ltd (ASX: WTC)

WiseTech has transformed global logistics software with its flagship CargoWise platform, which is now used by some of the biggest freight forwarders and supply-chain operators on the planet. Its model is sticky, scalable, and increasingly global, which is the kind of combination tech investors dream about.

However, the past year brought a rare step backwards in market sentiment. Founder controversies, delays to product launches, and a shift to its business model have led to a significant share price pullback. But none of these issues reflect a deterioration in the long-term fundamentals.

CargoWise continues to expand its reach through acquisitions, large enterprise customers are deepening their usage, and WiseTech is still growing at a strong rate.

If its performance improves, it stays clear of further controversies, and transitions successfully to its new business model in 2026, I think the rebound could be sharp for this blue chip ASX share.

Motley Fool contributor James Mickleboro has positions in CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Contented looking man leans back in his chair at his desk and smiles.
Blue Chip Shares

CBA vs Telstra: Which ASX blue-chip is better for passive income?

Commonwealth Bank or Telstra for your next passive income buy? I compare yields, franking, and my top pick for income…

Read more »

Woman and man at work looking at data on a tablet at work.
Opinions

Buy, hold, sell: BHP, CSL, and Westpac shares

I take a closer look at how I would approach these three major ASX shares today.

Read more »

Young businesswoman sitting in kitchen and working on laptop.
Blue Chip Shares

Could Wesfarmers shares reach $100 in 2027

I crunch the numbers to see what it would take for the retail giant to reach triple figures.

Read more »

Increasing stack of blue chips with a rising red arrow.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These major businesses are solid options for dividends…

Read more »

A woman in a sparkly dress smiles knowingly as she holds up two blue casino gambling chips in her hand next to her face.
Blue Chip Shares

2 ASX blue-chip shares that won't be hit by $100 oil

Higher oil hits some ASX shares harder than others.

Read more »

Couple on their laptop in their home kitchen.
Blue Chip Shares

Telstra vs NAB: Which ASX blue chip is the better buy?

I'm tipping Telstra over NAB for a better balance of income, franking, and recent share price momentum right now.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Woolworths and CBA shares

A leading expert believes investors would do well to exit their Woolworths and CBA share holdings. But why?

Read more »

Person holding a blue chip.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These stocks could provide investors with pleasing passive income.

Read more »